The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yassai, M.
Right arrow Articles by Gorski, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yassai, M.
Right arrow Articles by Gorski, J.
The Journal of Immunology, 2000, 165: 3706-3712.
Copyright © 2000 by The American Association of Immunologists

Thymocyte Maturation: Selection for In-Frame TCR {alpha}-Chain Rearrangement Is Followed by Selection for Shorter TCR ß-Chain Complementarity-Determining Region 31

Maryam Yassai and Jack Gorski2

The Blood Research Institute, The Blood Center of Southeastern Wisconsin, Milwaukee WI 53201

Thymocyte maturation consists of a number of stages, the goal of which is the production of functioning T cells that respond to foreign antigenic peptides using their clonotypic receptors. Selection of a productively rearranged TCR ß-chain is the first stage in the process and occurs at the double-negative to double-positive (DP) transition. Later maturation stages are based on changes in markers such as CD5, CD69, or IL-7R. A stage in which {alpha}-chains are selected has also been identified using ß-chain transgenic mice. Here we identify two additional selection stages in human thymocytes based on characteristics of the TCR. {alpha} selection is measured directly by identification of in-frame rearrangements and is associated with the appearance of CD3 on the DP thymocyte surface. The next stage has not yet been described and involves selection of thymocytes that express shorter TCR ß-chain complementarity-determining region 3 (CDR3). This stage is associated with the acquisition of high levels of CDR3 by DP cells and the transition to SP thymocytes. The extent of CDR3 length selection observed is a function of the TCR V and J genes. We propose that CDR3 length selection is based on recognition of the MHC. Thus, there exist limitations on the allowable length of that portion of the TCR most intimately in contact with MHC and peptide. This may be a physical representation of positive selection.




This article has been cited by other articles:


Home page
J. Immunol.Home page
A. C. Carpenter, K. S. Yang-Iott, L. H. Chao, B. Nuskey, S. Whitlow, F. W. Alt, and C. H. Bassing
Assembled DJ{beta} Complexes Influence TCR{beta} Chain Selection and Peripheral V{beta} Repertoire
J. Immunol., May 1, 2009; 182(9): 5586 - 5595.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. L. Furmanski, C. Ferreira, I. Bartok, S. Dimakou, J. Rice, F. K. Stevenson, M. M. Millrain, E. Simpson, and J. Dyson
Public T Cell Receptor -Chains Are Not Advantaged during Positive Selection
J. Immunol., January 15, 2008; 180(2): 1029 - 1039.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
J. Nishio, M. Suzuki, T. Nanki, N. Miyasaka, and H. Kohsaka
Development of TCRB CDR3 length repertoire of human T lymphocytes
Int. Immunol., March 1, 2004; 16(3): 423 - 431.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Yassai, K. Ammon, J. Goverman, P. Marrack, Y. Naumov, and J. Gorski
A Molecular Marker for Thymocyte-Positive Selection: Selection of CD4 Single-Positive Thymocytes with Shorter TCRB CDR3 During T Cell Development
J. Immunol., April 15, 2002; 168(8): 3801 - 3807.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.